{
    "2018-11-07": [
        [
            {
                "time": "2018-11-07",
                "original_text": "After Hours Most Active for Nov 7, 2018: V, LIN, S, USX, CTL, PFE",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "These 5 Dow Jones Stocks Just Made This Bullish Move",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Bullish Move"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "What AbbVie’s Bottom Line Trend Indicates",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bottom Line",
                        "Trend"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "A Look at AbbVie’s Operational Performance",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Operational Performance"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "How AbbVie Is Positioned in November",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Positioned",
                        "November"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "MARKETS: Oil heading into bear market territory",
                "features": {
                    "keywords": [
                        "Oil",
                        "Bear Market"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Pfizer Rises 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "'We have a lot of things in common' — Trump wants to work with Democrats on infrastructure, drugs",
                "features": {
                    "keywords": [
                        "Trump",
                        "Democrats",
                        "Infrastructure",
                        "Drugs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "infrastructure"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election",
                "features": {
                    "keywords": [
                        "Tariffs",
                        "Drug Prices",
                        "Legislative Gridlock",
                        "Midterm Election"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "NMC Healthcare Sukuk Limited -- Moody's assigns Ba1 rating to NMC's trust certificates",
                "features": {
                    "keywords": [
                        "NMC Healthcare",
                        "Moody's",
                        "Ba1 Rating"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Why Nektar Therapeutics Fell 36.5% in October",
                "features": {
                    "keywords": [
                        "Nektar Therapeutics",
                        "Fell"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Sanofi Eczema Drug Dupixent's sBLA Gets Priority Review",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Dupixent",
                        "Priority Review"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Health Care Sector Update for 11/07/2018: INGN, AXDX, FOMX, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Ex-Dividend Date"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Why Pfizer’s Rare Disease Portfolio Offers a Unique Opportunity",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Rare Disease",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 11/7/2018",
                "features": {
                    "keywords": [
                        "Validea",
                        "O'Shaughnessy",
                        "Strategy",
                        "Upgrade Report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}